Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease

by Robert Y. K. Lai, Charles R. Harrington, Claude M. Wischik
Published 2016-04-01

Erratum: Lai, R.Y.K.; Harrington, C.R.; Wischik, C.M. Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease. Biomolecules 2016, 6, 19

by Robert Y. K. Lai, Charles R. Harrington, Claude M. Wischik
Published 2016-08-01

Tau Filament Self-Assembly and Structure: Tau as a Therapeutic Target

by Sebastian S. Oakley, Mahmoud B. Maina, Mahmoud B. Maina, Karen E. Marshall, Youssra K. Al-Hilaly, Youssra K. Al-Hilaly, Charlie R. Harrington, Charlie R. Harrington, Claude M. Wischik, Claude M. Wischik, Louise C. Serpell
Published 2020-11-01

Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks

by Karima Schwab, Valeria Melis, Charles R. Harrington, Claude M. Wischik, Mandy Magbagbeolu, Franz Theuring, Gernot Riedel
Published 2021-08-01

Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer’s Disease

by Mohammad Arastoo, Richard Lofthouse, Lewis K. Penny, Charles R. Harrington, Andy Porter, Claude M. Wischik, Soumya Palliyil
Published 2020-11-01

Oxidative Stress Conditions Result in Trapping of PHF-Core Tau (297–391) Intermediates

by Mahmoud B. Maina, Youssra K. Al-Hilaly, Gunasekhar Burra, Janet E. Rickard, Charles R. Harrington, Claude M. Wischik, Louise C. Serpell
Published 2021-03-01

A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy

by Karima Schwab, Silke Frahm, David Horsley, Janet E. Rickard, Valeria Melis, Elizabeth A. Goatman, Mandy Magbagbeolu, Morag Douglas, Michael G. Leith, Thomas C. Baddeley, Thomas C. Baddeley, John M. D. Storey, John M. D. Storey, Gernot Riedel, Claude M. Wischik, Claude M. Wischik, Charles R. Harrington, Charles R. Harrington, Franz Theuring
Published 2018-01-01

Lewy Body Variant of Alzheimer's Disease: Selective Neocortical Loss of t-SNARE Proteins and Loss of MAP2 and α-Synuclein in Medial Temporal Lobe

by Elizabeta B. Mukaetova-Ladinska, John H. Xuereb, Francisco Garcia-Sierra, Jenny Hurt, Herman-J. Gertz, Richard Hills, Carol Brayne, Felicia A. Huppert, Eugene S. Paykel, Magnus A. McGee, Ross Jakes, William G. Honer, Charles R. Harrington, Claude M. Wischik, CC75C Collaboration Group
Published 2009-01-01